|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/137 | |
| A61K 9/16 | |||
| A61K 9/20 | |||
| A61P 25/00 |
| (11) | Number of the document | 1626709 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04709870.2 |
| Date of filing the European patent application | 2004-02-10 | |
| (97) | Date of publication of the European application | 2006-02-22 |
| (45) | Date of publication and mention of the grant of the patent | 2007-09-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2004/003821 |
| Date | 2004-02-10 |
| (87) | Number | WO 2004/071501 |
| Date | 2004-08-26 |
| (30) | Number | Date | Country code |
| 445793 P | 2003-02-10 | US | |
| 473925 P | 2003-05-29 | US |
| (72) |
COUCH, Richard, A., US
MICHAELS, A. Shire Pharmaceutical Development Inc., US
HODGKINS, Paul, US
|
| (73) |
Shire Canada Inc.,
275 Armand Frappier Coulevard, Laval, QC H7V 4A7,
CA
|
| (54) | ENANTIOMERIC AMPHETAMINE COMPOSITIONS FOR THE TREATMENT OF ADHD |
| ENANTIOMERIC AMPHETAMINE COMPOSITIONS FOR THE TREATMENT OF ADHD |